Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Non Operating Income (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Non Operating Income for 8 consecutive years, with $6.7 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 5.08% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, down 83.38% year-over-year, with the annual reading at $5.5 million for FY2025, 83.38% down from the prior year.
  • Non Operating Income for Q4 2025 was $6.7 million at Precision Biosciences, up from -$1.1 million in the prior quarter.
  • The five-year high for Non Operating Income was $12.8 million in Q1 2024, with the low at -$7.3 million in Q4 2022.
  • Average Non Operating Income over 5 years is $1.9 million, with a median of $174500.0 recorded in 2023.
  • The sharpest move saw Non Operating Income soared 31137.04% in 2021, then tumbled 6270.83% in 2022.
  • Over 5 years, Non Operating Income stood at $8.4 million in 2021, then crashed by 186.77% to -$7.3 million in 2022, then surged by 119.9% to $1.5 million in 2023, then surged by 387.71% to $7.1 million in 2024, then fell by 5.08% to $6.7 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $6.7 million, -$1.1 million, and -$1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.